Activin A suppresses neuroblastoma xenograft tumor growth via antimitotic and antiangiogenic mechanisms
dc.contributor.author | Panopoulou, E. | en |
dc.contributor.author | Murphy, C. | en |
dc.contributor.author | Rasmussen, H. | en |
dc.contributor.author | Bagli, E. | en |
dc.contributor.author | Rofstad, E. K. | en |
dc.contributor.author | Fotsis, T. | en |
dc.date.accessioned | 2015-11-24T19:38:10Z | |
dc.date.available | 2015-11-24T19:38:10Z | |
dc.identifier.issn | 0008-5472 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/24117 | |
dc.rights | Default Licence | - |
dc.subject | Activin Receptors/metabolism | en |
dc.subject | Activins/*therapeutic use | en |
dc.subject | Angiogenesis Inhibitors/*therapeutic use | en |
dc.subject | Animals | en |
dc.subject | Antineoplastic Agents/*therapeutic use | en |
dc.subject | Cell Cycle Proteins/metabolism | en |
dc.subject | Cell Movement/drug effects | en |
dc.subject | Cell Proliferation/drug effects | en |
dc.subject | Cyclin-Dependent Kinase Inhibitor p15 | en |
dc.subject | Cyclin-Dependent Kinase Inhibitor p21 | en |
dc.subject | Cyclin-Dependent Kinase Inhibitor p27 | en |
dc.subject | DNA-Binding Proteins/metabolism | en |
dc.subject | Endothelial Cells/*drug effects/metabolism | en |
dc.subject | Female | en |
dc.subject | *Gene Expression Regulation, Neoplastic | en |
dc.subject | Humans | en |
dc.subject | Inhibin-beta Subunits/*therapeutic use | en |
dc.subject | Mice | en |
dc.subject | Mice, Inbred BALB C | en |
dc.subject | Mice, Nude | en |
dc.subject | Neovascularization, Pathologic | en |
dc.subject | Neuroblastoma/metabolism/pathology/*prevention & control | en |
dc.subject | *Signal Transduction | en |
dc.subject | Smad2 Protein | en |
dc.subject | Smad3 Protein | en |
dc.subject | Trans-Activators/metabolism | en |
dc.subject | Tumor Cells, Cultured | en |
dc.subject | Tumor Suppressor Proteins/metabolism | en |
dc.subject | Vascular Endothelial Growth Factor Receptor-2/metabolism | en |
dc.subject | Xenograft Model Antitumor Assays | en |
dc.title | Activin A suppresses neuroblastoma xenograft tumor growth via antimitotic and antiangiogenic mechanisms | en |
heal.abstract | The tumor suppressor function of activin A, together with our findings that activin A is an inhibitor of angiogenesis, which is down-regulated by the N-MYC oncogene, prompted us to investigate in more detail its role in the malignant transformation process of neuroblastomas. Indeed, neuroblastoma cells with restored activin A expression exhibited a diminished proliferation rate and formed smaller xenograft tumors with reduced vascularity, whereas lung metastasis rate remained unchanged. In agreement with the decreased vascularity of the xenograft tumors, activin A inhibited several crucial angiogenic responses of cultured endothelial cells, such as proteolytic activity, migration, and proliferation. Endothelial cell proliferation, activin A, or its constitutively active activin receptor-like kinase 4 receptor (ALK4T206D), increased the expression of CDKN1A (p21), CDKN2B (p15), and CDKN1B (p27) CDK inhibitors and down-regulated the expression of vascular endothelial growth factor receptor-2, the receptor of a key angiogenic factor in cancer. The constitutively active forms of SMAD2 and SMAD3 were both capable of inhibiting endothelial cell proliferation, whereas the dominant-negative forms of SMAD3 and SMAD4 released the inhibitory effect of activin A on endothelial cell proliferation by only 20%. Thus, the effects of activin A on endothelial cell proliferation seem to be conveyed via the ALK4/SMAD2-SMAD3 pathways, however, non-SMAD cascades may also contribute. These results provide novel information regarding the role of activin A in the malignant transformation process of neuroblastomas and the molecular mechanisms involved in regulating angiogenesis thereof. | en |
heal.access | campus | - |
heal.fullTextAvailability | TRUE | - |
heal.identifier.primary | 10.1158/0008-5472.CAN-04-2828 | - |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/15753386 | - |
heal.identifier.secondary | http://cancerres.aacrjournals.org/content/65/5/1877.full.pdf | - |
heal.journalName | Cancer Res | en |
heal.journalType | peer-reviewed | - |
heal.language | en | - |
heal.publicationDate | 2005 | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.type | journalArticle | - |
heal.type.el | Άρθρο Περιοδικού | el |
heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: